BREAKING
NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago
ADVERTISEMENT

Earnings: Vuzix disappoints in Q4, stock declines

Vuzix (VUZI) Friday reported fourth-quarter losses that were wider than what the street anticipated, on revenues that missed analysts’ estimates. The supplier of smart glasses and augmented reality (AR) technologies said its Q4 losses narrowed to 22 cents per share from 29 cents per share a year ago. The street was, meanwhile, looking at a […]

March 15, 2019 2 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results

Vuzix (VUZI) Friday reported fourth-quarter losses that were wider than what the street anticipated, on revenues that missed analysts’ estimates. The supplier of smart glasses and augmented reality (AR) technologies said its Q4 losses narrowed to 22 cents per share from 29 cents per share a year ago. The street was, meanwhile, looking at a […]

Vuzix (VUZI) Friday reported fourth-quarter losses that were wider than what the street anticipated, on revenues that missed analysts’ estimates. The supplier of smart glasses and augmented reality (AR) technologies said its Q4 losses narrowed to 22 cents per share from 29 cents per share a year ago. The street was, meanwhile, looking at a loss of 18 cents per share.

Revenue for the quarter increased 24% to $1.98 million, but missed the analysts’ consensus by over a million dollars. The top line was lifted by its sale of smart glasses, including Toshiba Smart Glasses, which grew 33% year-over-year.

VUZI shares fell 4.2% following the disappointing results. The stock has tumbled 50% in the trailing 12-month period.

READ: DOCUSIGN SURPRISES WALL STREET WITH A PROFIT IN Q4

CEO Paul Travers said, “Operationally, we continued to steadily grow our top-line in our fourth quarter of 2018, achieving Q4 year-over-year revenue growth of 24% on increased sales of our AR smart glasses, and continued our ongoing evaluation of operating expenses to ensure the most rapid path to profitability possible.”

Research and Development expense for the quarter was $3.3 million, up 43%, primarily due to the development costs for M400 Smart Glasses and an increase in external software development costs for the Blade.

The Rochester, New York-based company said it expects to expand both new and existing OEM relationships as the year progresses, as well as continue ramp production of the Blade in 2019.

Earnings Calendar: Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT